WHO WE ARE
AMPEL BioSolutions is a precision medicine company. Profitability from in-house clinical trial design/management and AMPEL Genomic Platform (AGP®) fueled R&D for LuGENE®, a gene-based diagnostic for lupus patients to determine disease status, predict flares & match patients with best drug options. Current customers are Pharma to accelerate trial success by enrolling patients into trials that express drug target/pathway. Funding will scale and commercialize LuGENE® for the decision support markets (MD/patient and payors). AMPEL's technology extends into other diseases.
At BioBuzz, we’re dedicated to bringing you interesting and important stories that emerge from the thriving life sciences…